Fertility warning
This medicine may affect fertility.
Leaflet DASATINIB TEVA 70mg film-coated tablets
Precautions:
Cytotoxic / special handling
Handle with special care.
Contraception required
Effective contraception is required during treatment.
Contraindicated during breastfeeding
Do not use this medicine while breastfeeding.
Contraindicated during pregnancy
Do not use this medicine during pregnancy.
Avoid grapefruit
Avoid grapefruit and grapefruit juice.
Hepatotoxicity
This medicine may affect the liver.
Major drug interactions
This medicine may have important interactions with other medicines.
Myelosuppression / agranulocytosis
This medicine may lower blood cell counts.
Additional monitoring
This medicine is subject to additional monitoring.
Requires periodic laboratory tests
Periodic laboratory tests may be required during treatment.
Severe skin reactions
Stop taking the medicine and seek urgent medical help if a severe rash occurs.
Cardiac risk / QT prolongation / arrhythmias
This medicine may increase the risk of heart rhythm disturbances.
Dasatinib is a medication used for the treatment of chronic myeloid leukemia (CML) and acute lymphoblastic leukemia (ALL) with Philadelphia chromosome positivity. It acts as a tyrosine kinase inhibitor, blocking signals that promote cancer cell growth.
The medication is taken orally, usually once daily, and is effective in reducing the number of leukemic cells and prolonging patient survival. It is used in both chronic and advanced phases of the disease.
Side effects may include fluid retention, nausea, diarrhea, fatigue, and muscle pain. In rare cases, severe complications such as pulmonary hypertension or bone marrow suppression may occur. Regular monitoring is essential.
Consult your doctor to discuss the benefits and risks of treatment with Dasatinib. Follow the prescribed dosage and adhere to all medical recommendations.
The medication is taken orally, usually once daily, and is effective in reducing the number of leukemic cells and prolonging patient survival. It is used in both chronic and advanced phases of the disease.
Side effects may include fluid retention, nausea, diarrhea, fatigue, and muscle pain. In rare cases, severe complications such as pulmonary hypertension or bone marrow suppression may occur. Regular monitoring is essential.
Consult your doctor to discuss the benefits and risks of treatment with Dasatinib. Follow the prescribed dosage and adhere to all medical recommendations.
General data about DASATINIB TEVA 70mg
- Substance:
- dasatinib
- Date of latest medicines list:
- 01-06-2026
- Product code:
- W69649004
- Concentration:
- 70mg
- Pharmaceutical form:
- film-coated tablets
- Quantity:
- 60
- Product type:
- Generic medicine
- Price:
- 4872.04 RON
- Prescription status:
- P-RF — Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.
Concentrations available for dasatinib
- 100mg
- 111mg
- 140mg
- 16mg
- 20mg
- 40mg
- 50mg
- 55mg
- 63mg
- 70mg
- 79mg
- 80mg